GR871550B - Sustained release pharmaceutical compositions - Google Patents

Sustained release pharmaceutical compositions

Info

Publication number
GR871550B
GR871550B GR871550A GR870101550A GR871550B GR 871550 B GR871550 B GR 871550B GR 871550 A GR871550 A GR 871550A GR 870101550 A GR870101550 A GR 870101550A GR 871550 B GR871550 B GR 871550B
Authority
GR
Greece
Prior art keywords
pharmaceutical compositions
sustained release
release pharmaceutical
sustained
compositions
Prior art date
Application number
GR871550A
Other languages
Greek (el)
Inventor
Henry C Gan
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of GR871550B publication Critical patent/GR871550B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
GR871550A 1986-10-09 1987-10-07 Sustained release pharmaceutical compositions GR871550B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GR871550B true GR871550B (en) 1988-02-15

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
GR871550A GR871550B (en) 1986-10-09 1987-10-07 Sustained release pharmaceutical compositions

Country Status (24)

Country Link
JP (1) JPS63101334A (en)
KR (1) KR880004801A (en)
AU (1) AU7942087A (en)
BE (1) BE1000732A5 (en)
CA (1) CA1332809C (en)
CH (1) CH675831A5 (en)
DE (1) DE3733540A1 (en)
DK (1) DK527487A (en)
ES (1) ES2014518A6 (en)
FI (1) FI874414A (en)
FR (1) FR2604902B1 (en)
GB (2) GB8624213D0 (en)
GR (1) GR871550B (en)
HU (1) HU201875B (en)
IL (1) IL84104A0 (en)
IT (1) IT1221493B (en)
LU (1) LU87009A1 (en)
NL (1) NL8702294A (en)
NO (1) NO874200L (en)
NZ (1) NZ222083A (en)
PH (1) PH24227A (en)
PT (1) PT85880B (en)
SE (1) SE8703889L (en)
ZA (1) ZA877617B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
EP1649851B1 (en) * 1999-03-31 2018-06-20 Janssen Pharmaceutica NV Pregelatinized starch in a controlled release formulation
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102887D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102888D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
PL1803447T3 (en) * 2004-09-09 2010-05-31 Psicofarma S A De C V Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (en) * 1972-02-22 1973-08-22 Lilly Co Eli PROPOXYPHENE DELAY NAPSYLATE PARTICLES AND PROCESS FOR MANUFACTURING SUCH PARTICLES
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (en) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen ORAL RETARDED ACETYLSALICYL ACID FORMULATIONS
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules

Also Published As

Publication number Publication date
SE8703889L (en) 1988-04-10
DE3733540A1 (en) 1988-04-14
GB8723515D0 (en) 1987-11-11
HUT52958A (en) 1990-09-28
CA1332809C (en) 1994-11-01
NL8702294A (en) 1988-05-02
FR2604902B1 (en) 1991-04-26
PT85880B (en) 1990-07-31
IL84104A0 (en) 1988-03-31
FR2604902A1 (en) 1988-04-15
GB2195893A (en) 1988-04-20
CH675831A5 (en) 1990-11-15
DK527487D0 (en) 1987-10-08
NO874200L (en) 1988-04-11
GB2195893B (en) 1991-05-08
IT8748469A0 (en) 1987-10-08
AU7942087A (en) 1988-04-14
FI874414A (en) 1988-04-10
PT85880A (en) 1987-11-01
DK527487A (en) 1988-04-10
LU87009A1 (en) 1988-05-03
HU201875B (en) 1991-01-28
ES2014518A6 (en) 1990-07-16
NO874200D0 (en) 1987-10-07
SE8703889D0 (en) 1987-10-08
GB8624213D0 (en) 1986-11-12
KR880004801A (en) 1988-06-27
IT1221493B (en) 1990-07-06
BE1000732A5 (en) 1989-03-21
NZ222083A (en) 1991-05-28
JPS63101334A (en) 1988-05-06
PH24227A (en) 1990-05-04
FI874414A0 (en) 1987-10-07
ZA877617B (en) 1989-05-30

Similar Documents

Publication Publication Date Title
GB2230185B (en) Sustained release pharmaceutical compositions
GB2196964B (en) Pharmaceutical compositions
AR243378A1 (en) Sustained release pharmaceutical composition
GB8716301D0 (en) Pharmaceutical compositions
GB8717582D0 (en) Pharmaceutical compositions
GB8714625D0 (en) Pharmaceutical compositions
GB8608818D0 (en) Pharmaceutical compositions
GB8717581D0 (en) Pharmaceutical compositions
IL82924A0 (en) Sustained release pharmaceutical compositions containing katotifen
GB8618259D0 (en) Pharmaceutical compositions
GB2190838B (en) Pharmaceutical compositions
GB8629781D0 (en) Pharmaceutical compositions
ZA904925B (en) Sustained release pharmaceutical compositions
GB2195893B (en) Sustained release pharmaceutical compositions
GB8723118D0 (en) Pharmaceutical compositions
GB2188235B (en) Pharmaceutical compositions
GB8620073D0 (en) Pharmaceutical compositions
GB8621756D0 (en) Pharmaceutical compositions
GB8713566D0 (en) Pharmaceutical compositions
GB8624214D0 (en) Sustained release pharmaceutical compositions
GB8413796D0 (en) Sustained release pharmaceutical compositions
GB8413797D0 (en) Sustained release pharmaceutical compositions
GB8616695D0 (en) Pharmaceutical compositions
GB8628476D0 (en) Pharmaceutical compositions
GB8626217D0 (en) Pharmaceutical compositions